Developer docs
API playgroundTry for free, no card

Search company profiles

Hemovent

Full company profile

uuid0003e6x

Namestring
Hemovent
Legal namestring
Hemovent GmbH
Websiteurl
hemovent.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Hemovent GmbH, founded in 2013 and headquartered in Aachen, Germany, is a privately held medical device company that develops and manufactures mobile extracorporeal life support (ECLS) systems. Its core products are the MOBYBOX™, the first fully pneumatically driven ECLS system that integrates a biventricular displacement pump and gas exchanger in a single ~2 kg unit operating without external electricity or software, and the MOBYO™, a standalone round-design gas exchanger (oxygenator) with flow-optimized geometry that can be paired with the MOBYBOX or with most conventional rotational pumps. The 12+ worldwide patents, ISO 13485:2016 quality management certification, and CE marking under EU MDR 2017/745 (14-day intended use for MOBYBOX, 28-day for MOBYO) form the technical and regulatory backbone of the business.

The company's go-to-market is sales-led B2B, targeting hospitals and healthcare institutions through direct consultation requests addressed to intensive care, emergency medicine, anesthesiology, and cardiac catheterization departments. Use cases span emergency resuscitation, ARDS, cardiogenic failure, septic shock, high-risk PCI in cath labs, and intra/inter-hospital transport of ECLS patients. The hardware-centric product positioning—differentiating on rapid ~5-minute setup, mobility, shock-resistance, and reduced blood trauma via pulsatile flow—is the primary commercial narrative, supported by participation in international medical conferences and peer-reviewed publications in Ann Thorac Surg and ASAIO Journal. Revenue is generated through capital-equipment sales with quote-based pricing to enterprise healthcare buyers; specific contract values and unit volumes are not disclosed.

Since the late 2010s, Hemovent has operated under the umbrella of Microport MedTech, a global medical technology corporation, retaining its Aachen headquarters and cleanroom manufacturing facility and 100% in-house development. The disclosed funding history includes a $6.0M round in February 2016 led by MIG Capital, a ~$2.33M round in July 2017, and a $5.2M round in February 2019; no further capital raises are evidenced in the input. Day-to-day leadership is held by Managing Director Frank Schanne, alongside co-founder Christof Lenz (CEO) and CTO Oliver Marseille.

Short descriptiontext

Hemovent GmbH, headquartered in Aachen, Germany, develops and manufactures the MOBYBOX and MOBYO—compact, fully pneumatic ECLS and oxygenator systems—selling them CE-marked as capital equipment to hospitals for emergency, intensive care, transport, and cath-lab use.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAachen, Germany
HQ citystring
Aachen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
extracorporeal life support, medical device manufacturing, cardiac respiratory support, ECMO systems, pneumatic oxygenation
Industry2 codes
PRIMARYHLAHAFAG
Mechanical Circulatory Support (VAD, IABP, ECMO)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Extracorporeal Life Support (ECLS) Medical Devices
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Hemovent generates revenue through the sale of its medical devices including the MOBYBOX ECLS system and MOBYO oxygenator. As a medical device manufacturer, the company sells hardware products to hospitals and healthcare institutions.

hemovent.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based pricing for hospitals and healthcare institutions
ModelOtherBilling cadenceMulti-year contract
Notes

Product pricing is not publicly disclosed on the website. Consultation and quote requests are available through the contact form for healthcare professionals.

hemovent.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1MOBYBOX™
Description

A compact, fully pneumatically driven ECLS (Extracorporeal Membrane Oxygenation) system that combines a displacement pump and gas exchanger in one unit. Weighs approximately 2kg and operates without external power or software.

hemovent.com
+1 more record
Core offering1 text field

Hemovent designs, manufactures, and sells the MOBYBOX™, a compact (~2 kg) fully pneumatically driven extracorporeal life support (ECLS) system that integrates a biventricular displacement pump and gas exchanger in a single unit requiring no external electrical power or software. The company also sells the MOBYO™, a stand-alone round-design oxygenator compatible with both the MOBYBOX and conventional rotational pumps, targeting emergency resuscitation, cardiac and pulmonary support, transport, and patient mobilization in hospitals and ICUs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Setup time of approximately 5 minutes
+4 more records
Product overview1 text field

Hemovent offers two modular ECLS (extracorporeal life support) products: the MOBYBOX™ as the core integrated system and the MOBYO™ as a standalone oxygenator module. The MOBYBOX™ is a fully pneumatically driven, compact ECLS unit combining a displacement pump and gas exchanger in one ~2 kg device, requiring no external power or software, and supporting both veno-venous and veno-arterial configurations for emergency, stabilization, transport, and patient mobilization. The MOBYO™ serves as a flow-optimized, round-design gas exchanger that functions as an integral component of the MOBYBOX™ system and can also be paired independently with conventional rotational pumps. Both products are manufactured in-house in Aachen, Germany, and carry CE marking under MDR 2017/745.

Product and service2 records
1MOBYBOX™
CategoryExtracorporeal Life Support (ECLS) System
Description

The MOBYBOX™ is a fully pneumatically driven, compact (~2 kg) extracorporeal life support (ECLS) system integrating a biventricular displacement pump and gas exchanger into a single unit. It supports veno-venous and veno-arterial heart/lung configurations, requires no external power or software, and is targeted at emergency, stabilization, transport, and patient mobilization use in ICUs, emergency departments, cath labs, and field settings. CE certified under MDR 2017/745 with a 14-day intended use.

2MOBYO™
CategoryGas Exchanger / Oxygenator
Description

The MOBYO™ is a standalone round-design gas exchanger (oxygenator) with flow-optimized geometry that minimizes stagnation areas and thrombus formation. It functions as an integral component of the MOBYBOX system and can also be paired independently with most conventional rotational pumps. Supports blood flows up to 7 L/min, ships as a complete set including tubing, clamps, scissors, and a deaeration kit, and is CE certified under MDR with a 28-day intended use.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-01-01
Description

Hemovent operates under the umbrella of Microport MedTech, a global medical technology corporation. Today, the headquarters and production facility with clean room in Aachen operate under the Microport group. This provides Hemovent with the resources and global reach of a major MedTech corporation while maintaining its innovation lab and development operations in Aachen.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in ECLS/ECMO via the Maquet Cardiohelp system, the dominant installed base in ICUs worldwide. Directly comparable as a full ECLS platform competitor, with deep clinical-evidence, KOL relationships, and global service infrastructure.

TypeBroad incumbent
Description

Sells the Affinity family of centrifugal blood pumps and oxygenators used in ECLS circuits. Comparable as a broad incumbent with overlapping ECLS hardware, much larger R&D and hospital sales coverage.

TypeDirect peer
Description

Markets the TandemLife / LifeSPARC ECLS platform for ECMO and temporary mechanical circulatory support. Closely comparable in product category (portable ECMO/ECLS) and target clinical use case.

TypeDirect peer
Description

Acquired Xenios to build an ECLS/ECMO franchise around the i-cor and Hilite product lines. Direct competitor in mini-invasive and respiratory/circulatory support, sharing the same European intensivist customer base.

5Terumo Corporation
TypeBroad incumbent
Description

Sells perfusion systems, centrifugal pumps, and oxygenators used in cardiac surgery and ECMO. Comparable as a broad incumbent with overlapping cardiopulmonary hardware and global hospital reach.

6Spectrum Medical
TypeEmerging player
Description

UK-based specialist in extracorporeal support equipment including Quantum and other perfusion/ECLS technologies. Comparable as a focused ECLS challenger, similar in scale and product niche.

TypeEmerging player
Description

Italian manufacturer of ECMO and ECLS devices including oxygenators and pumps. Direct product overlap with MOBYBOX/MOBYO; comparable as a smaller European ECLS specialist competing for similar hospital accounts.

8Nipro Corporation
TypeRegional player
Description

Japan-headquartered medtech firm selling ECMO/cardiopulmonary support systems and consumables into Asian and select global markets. Comparable product overlap in oxygenators and ECLS hardware, primarily regional rather than Europe-centric.

TypeBroad incumbent
Description

Acquired Abiomed for its Impella percutaneous ventricular assist devices — adjacent but overlapping in temporary mechanical circulatory support sales motion to the same ICU/cath-lab customers Hemovent targets.

TypeEmerging player
Description

Specialist in mechanical circulatory support (ventricular assist devices) used in pediatric and adult cardiac failure. Comparable as a focused cardiovascular-support device specialist in overlapping clinical indications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hemovent

Extracorporeal Life Support (ECLS) Medical Deviceshemovent.com

Hemovent GmbH, headquartered in Aachen, Germany, develops and manufactures the MOBYBOX and MOBYO—compact, fully pneumatic ECLS and oxygenator systems—selling them CE-marked as capital equipment to hospitals for emergency, intensive care, transport, and cath-lab use.

What Hemovent does

Hemovent GmbH, founded in 2013 and headquartered in Aachen, Germany, is a privately held medical device company that develops and manufactures mobile extracorporeal life support (ECLS) systems. Its core products are the MOBYBOX™, the first fully pneumatically driven ECLS system that integrates a biventricular displacement pump and gas exchanger in a single ~2 kg unit operating without external electricity or software, and the MOBYO™, a standalone round-design gas exchanger (oxygenator) with flow-optimized geometry that can be paired with the MOBYBOX or with most conventional rotational pumps. The 12+ worldwide patents, ISO 13485:2016 quality management certification, and CE marking under EU MDR 2017/745 (14-day intended use for MOBYBOX, 28-day for MOBYO) form the technical and regulatory backbone of the business.

The company's go-to-market is sales-led B2B, targeting hospitals and healthcare institutions through direct consultation requests addressed to intensive care, emergency medicine, anesthesiology, and cardiac catheterization departments. Use cases span emergency resuscitation, ARDS, cardiogenic failure, septic shock, high-risk PCI in cath labs, and intra/inter-hospital transport of ECLS patients. The hardware-centric product positioning—differentiating on rapid ~5-minute setup, mobility, shock-resistance, and reduced blood trauma via pulsatile flow—is the primary commercial narrative, supported by participation in international medical conferences and peer-reviewed publications in Ann Thorac Surg and ASAIO Journal. Revenue is generated through capital-equipment sales with quote-based pricing to enterprise healthcare buyers; specific contract values and unit volumes are not disclosed.

Since the late 2010s, Hemovent has operated under the umbrella of Microport MedTech, a global medical technology corporation, retaining its Aachen headquarters and cleanroom manufacturing facility and 100% in-house development. The disclosed funding history includes a $6.0M round in February 2016 led by MIG Capital, a ~$2.33M round in July 2017, and a $5.2M round in February 2019; no further capital raises are evidenced in the input. Day-to-day leadership is held by Managing Director Frank Schanne, alongside co-founder Christof Lenz (CEO) and CTO Oliver Marseille.

Hemovent firmographics

Firmographics
Name
Hemovent
Legal name
Hemovent GmbH
Website
https://hemovent.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Hemovent GmbH, headquartered in Aachen, Germany, develops and manufactures the MOBYBOX and MOBYO—compact, fully pneumatic ECLS and oxygenator systems—selling them CE-marked as capital equipment to hospitals for emergency, intensive care, transport, and cath-lab use.
Ownership category
akta.pro rank

Hemovent industry classification

Industry
Product category
Extracorporeal Life Support (ECLS) Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAFAG
Mechanical Circulatory Support (VAD, IABP, ECMO)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Extracorporeal life support
  • Medical device manufacturing
  • Cardiac respiratory support
  • ECMO systems
  • Pneumatic oxygenation

Where Hemovent is headquartered

Location

Headquarters

HQ city
Aachen
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Hemovent business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Hemovent generates revenue through the sale of its medical devices including the MOBYBOX ECLS system and MOBYO oxygenator. As a medical device manufacturer, the company sells hardware products to hospitals and healthcare institutions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for hospitals and healthcare institutions

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Hemovent product offering

Product offering

Core offering

Hemovent designs, manufactures, and sells the MOBYBOX™, a compact (~2 kg) fully pneumatically driven extracorporeal life support (ECLS) system that integrates a biventricular displacement pump and gas exchanger in a single unit requiring no external electrical power or software. The company also sells the MOBYO™, a stand-alone round-design oxygenator compatible with both the MOBYBOX and conventional rotational pumps, targeting emergency resuscitation, cardiac and pulmonary support, transport, and patient mobilization in hospitals and ICUs.

Product overview

Hemovent offers two modular ECLS (extracorporeal life support) products: the MOBYBOX™ as the core integrated system and the MOBYO™ as a standalone oxygenator module. The MOBYBOX™ is a fully pneumatically driven, compact ECLS unit combining a displacement pump and gas exchanger in one ~2 kg device, requiring no external power or software, and supporting both veno-venous and veno-arterial configurations for emergency, stabilization, transport, and patient mobilization. The MOBYO™ serves as a flow-optimized, round-design gas exchanger that functions as an integral component of the MOBYBOX™ system and can also be paired independently with conventional rotational pumps. Both products are manufactured in-house in Aachen, Germany, and carry CE marking under MDR 2017/745.

Differentiator

Problem solved

Functional benefit

Brands

  • MOBYBOX™: A compact, fully pneumatically driven ECLS (Extracorporeal Membrane Oxygenation) system that combines a displacement pump and gas exchanger in one unit. Weighs approximately 2kg and operates without external power or software.
  • MOBYO™

Products and services

  • MOBYBOX™ The MOBYBOX™ is a fully pneumatically driven, compact (~2 kg) extracorporeal life support (ECLS) system integrating a biventricular displacement pump and gas exchanger into a single unit. It supports veno-venous and veno-arterial heart/lung configurations, requires no external power or software, and is targeted at emergency, stabilization, transport, and patient mobilization use in ICUs, emergency departments, cath labs, and field settings. CE certified under MDR 2017/745 with a 14-day intended use.
  • MOBYO™ The MOBYO™ is a standalone round-design gas exchanger (oxygenator) with flow-optimized geometry that minimizes stagnation areas and thrombus formation. It functions as an integral component of the MOBYBOX system and can also be paired independently with most conventional rotational pumps. Supports blood flows up to 7 L/min, ships as a complete set including tubing, clamps, scissors, and a deaeration kit, and is CE certified under MDR with a 28-day intended use.

Quantifiable outcome

  • Setup time of approximately 5 minutes
  • +4 more outcomes

Companies that use Hemovent

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Hemovent technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Hemovent partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MicroportcoreStrategic or Co-development Partner · 1 January 2013Hemovent operates under the umbrella of Microport MedTech, a global medical technology corporation. Today, the headquarters and production facility with clean room in Aachen operate under the Microport group. This provides Hemovent with the resources and global reach of a major MedTech corporation while maintaining its innovation lab and development operations in Aachen.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Hemovent competitors and assessment

Company assessment

Broad incumbents

  • Getinge (Maquet Cardiohelp): Global leader in ECLS/ECMO via the Maquet Cardiohelp system, the dominant installed base in ICUs worldwide. Directly comparable as a full ECLS platform competitor, with deep clinical-evidence, KOL relationships, and global service infrastructure.
  • Medtronic: Sells the Affinity family of centrifugal blood pumps and oxygenators used in ECLS circuits. Comparable as a broad incumbent with overlapping ECLS hardware, much larger R&D and hospital sales coverage.
  • Terumo Corporation: Sells perfusion systems, centrifugal pumps, and oxygenators used in cardiac surgery and ECMO. Comparable as a broad incumbent with overlapping cardiopulmonary hardware and global hospital reach.
  • Abiomed (Johnson & Johnson): Acquired Abiomed for its Impella percutaneous ventricular assist devices — adjacent but overlapping in temporary mechanical circulatory support sales motion to the same ICU/cath-lab customers Hemovent targets.

Direct peers

  • LivaNova (TandemLife / LifeSPARC): Markets the TandemLife / LifeSPARC ECLS platform for ECMO and temporary mechanical circulatory support. Closely comparable in product category (portable ECMO/ECLS) and target clinical use case.
  • Fresenius Medical Care (Xenios): Acquired Xenios to build an ECLS/ECMO franchise around the i-cor and Hilite product lines. Direct competitor in mini-invasive and respiratory/circulatory support, sharing the same European intensivist customer base.

Emerging players

  • Spectrum Medical: UK-based specialist in extracorporeal support equipment including Quantum and other perfusion/ECLS technologies. Comparable as a focused ECLS challenger, similar in scale and product niche.
  • Eurosets: Italian manufacturer of ECMO and ECLS devices including oxygenators and pumps. Direct product overlap with MOBYBOX/MOBYO; comparable as a smaller European ECLS specialist competing for similar hospital accounts.
  • Berlin Heart: Specialist in mechanical circulatory support (ventricular assist devices) used in pediatric and adult cardiac failure. Comparable as a focused cardiovascular-support device specialist in overlapping clinical indications.

Regional players

  • Nipro Corporation: Japan-headquartered medtech firm selling ECMO/cardiopulmonary support systems and consumables into Asian and select global markets. Comparable product overlap in oxygenators and ECLS hardware, primarily regional rather than Europe-centric.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Hemovent social profiles

Digital presence

Hemovent compliance and trust

Trust signal

Compliance2 records

Hemovent financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hemovent leadership team

Management profile

Number of profiles

Profiles3 records

Hemovent funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hemovent M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hemovent

What does Hemovent do?

Hemovent designs, manufactures, and sells the MOBYBOX™, a compact (~2 kg) fully pneumatically driven extracorporeal life support (ECLS) system that integrates a biventricular displacement pump and gas exchanger in a single unit requiring no external electrical power or software. The company also sells the MOBYO™, a stand-alone round-design oxygenator compatible with both the MOBYBOX and conventional rotational pumps, targeting emergency resuscitation, cardiac and pulmonary support, transport, and patient mobilization in hospitals and ICUs.

Is Hemovent a public or private company?

Hemovent is a private company. It is classified as corporate owned and is currently operating.

When was Hemovent founded?

Hemovent was founded in 2013. It employs 11 to 50 people.

Where is Hemovent based?

Hemovent is headquartered in Aachen, Germany, in the Europe region.

How does Hemovent make money?

One revenue line is on record: medical Device Sales.

Who are Hemovent's main competitors?

Broad incumbents on record are Getinge (Maquet Cardiohelp), Medtronic, Terumo Corporation and Abiomed (Johnson & Johnson). Direct peers are LivaNova (TandemLife / LifeSPARC) and Fresenius Medical Care (Xenios). Emerging players are Spectrum Medical, Eurosets and Berlin Heart. Nipro Corporation is listed as a regional player.

Does Hemovent have an API?

No public API is recorded for Hemovent.

What industry is Hemovent in?

Hemovent's product category is Extracorporeal Life Support (ECLS) Medical Devices. Its primary akta.pro industry code is HLAHAFAG, Mechanical Circulatory Support (VAD, IABP, ECMO), with a secondary code of HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MicroportGerman ECLS Hemovent Acquisition & ExpansionMicroPort Scientific Corporation announced the acquisition of 100% equity in Hemovent GmbH for up to €123 million, making Hemovent a wholly-owned subsidiary. The deal integrates Hemovent's portable ECMO technology, the MOBYBOX®, into MicroPort's critical care portfolio to expand its presence in the extracorporeal life support market. Completion is expected in Q4 2021 following regulatory approvals.Business Wire BlogECLS Company Hemovent has been Acquired by MicroPort and Receives Investments in Expansion of German OperationsMicroPort Scientific Corporation has acquired 100% of Hemovent GmbH for up to €123 million, integrating the German medical device maker into its critical care subsidiary. The acquisition aims to expand MicroPort's portfolio in emergency and critical care by combining Cardiopulmonary Bypass expertise with Hemovent's MOBYBOX ECMO technology. Completion is expected in Q4/2021, with plans to pursue US FDA filing and clinical registration in China.FinSMEsHemovent Expands Series A FinancingHemovent GmbH, a German artificial lung developer, received an undisclosed funding extension of its Series A round, with new investor 1st Capital Partner joining existing backers. The company completed its first in vivo trials for its portable ECMO/ECLS system, which is not yet approved for human use.FinSMEsHemovent Closes $6M Series A FundingHemovent GmbH, a German medical device company, closed a $6 million Series A funding round led by MIG Verwaltungs AG. The company develops a portable ECMO system for cardiac and respiratory failure. The round also included participation from WCTI Partners, Seed Fond Aachen II, KfW Bank, NRW.BANK.Venture Fonds, and PB Beteiligung- und Vermoegensverwaltung.